COAPROVEL 150/12,5 TABLET South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

coaprovel 150/12,5 tablet

sanofi industries south africa (pty) ltd - tablet - see ingredients - each tablet contains hydrochlorothiazide 12,5 mg irbesartan 150,0 mg

Coaprovel 150/12,5 Namibia - English - Namibia Medicines Regulatory Council

coaprovel 150/12,5

aventis pharma (pty) limited - irbesartan , hydrochlorothiazide - tablets - each tablet contains irbesartan 150 mg, hydrochlorothiazide 12,5 mg

CoAprovel European Union - English - EMA (European Medicines Agency)

coaprovel

sanofi winthrop industrie - irbesartan, hydrochlorothiazide - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension. this fixed dose combination is indicated in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.

COAPROVEL FILM-COATED TABLET 15012.5 mg Singapore - English - HSA (Health Sciences Authority)

coaprovel film-coated tablet 15012.5 mg

sanofi-aventis singapore pte. ltd. - hydrochlorothiazide; irbesartan - tablet, film coated - 12.50 mg - hydrochlorothiazide 12.50 mg; irbesartan 150.00 mg

COAPROVEL FILM-COATED TABLET 30025mg Singapore - English - HSA (Health Sciences Authority)

coaprovel film-coated tablet 30025mg

sanofi-aventis singapore pte. ltd. - hydrochlorothiazide; irbesartan - tablet, film coated - 25.00mg - hydrochlorothiazide 25.00mg; irbesartan 300.00mg

COAPROVEL FILM-COATED TABLET 30012.5 mg Singapore - English - HSA (Health Sciences Authority)

coaprovel film-coated tablet 30012.5 mg

sanofi-aventis singapore pte. ltd. - hydrochlorothiazide; irbesartan - tablet, film coated - 12.50 mg - hydrochlorothiazide 12.50 mg; irbesartan 300.00 mg